Xiaoqi Ji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaoqi Ji has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Tobias Alexander Marius Gulder
Department of Natural Product Biotechnology, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Department of Pharmacy at Saarland University, PharmaScienceHub (PSH), 66123 Saarbrücken, Germany
3 shared publications - Jennifer Herrmann
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
2 shared publications - Manuel Einsiedler
Technische Universität Dresden
2 shared publications - Paul Michael D’aGostino
Saarland University, PharmaScienceHub (PSH)
2 shared publications - Rolf Müller
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) Saarbrücken Germany
2 shared publications - Norbert Sträter
Leipzig University
1 shared publication
Latest Publications
- Open Access
- 4 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Furanolide Tailoring Enzymology in Cyanobacterin Biosynthesis
Cyanobacterins are a class of bioactive natural products known for their potent algicidal and antitumor properties. In our previous work, we identified the cyanobacterin biosynthetic gene cluster and elucidated the biosynthesis of the furanolide core structure. However, the functions of all tailoring enzymes encoded within this cluster remained elusive. In this study, we utilized both, in vivo heterologous expression and in vitro biochemical assays, to investigate the roles of cyanobacterin biosynthetic tailoring enzymes. Extensive screening with a broad range of furanolide core structure analogs revealed a remarkable substrate promiscuity of these enzymes, making them valuable tools for biocatalytic late-stage diversification. In addition, an in-depth understanding of the biosynthetic sequence of the tailoring enzymes was obtained using early biosynthetic precursors: CybK, CybJ, and CybI sequentially orchestrate key cyanobacterin maturation steps, namely C10-hydroxylation, C10-O-methylation, and C8-chlorination, respectively. Following these modifications and subsequent furanolide core-structure assembly catalyzed by CybE/F, CybD installs the C17-methoxy group. Additionally, we identified and functionally characterized the ene-reductase CybG, which catalyzes the reduction of the C4-C13 double bond in cyanobacterins, transforming them into non-toxic saturated congeners. These insights not only enhance our understanding of the complex enzymatic pathway involved in cyanobacterin biosynthesis, but also facilitate the development of new tools for the enzymatic total synthesis of cyanobacterins and unnatural analogs, paving the way for future biotechnological applications.
- 4 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessFuranolide Tailoring Enzymology in Cyanobacterin Biosynthesis
Cyanobacterins are a class of bioactive natural products known for their potent algicidal and antitumor properties. In our previous work, we identified the cyanobacterin biosynthetic gene cluster and elucidated the biosynthesis of the furanolide core structure. However, the functions of all tailoring enzymes encoded within this cluster remained elusive. In this study, we utilized both, in vivo heterologous expression and in vitro biochemical assays, to investigate the roles of cyanobacterin biosynthetic tailoring enzymes. Extensive screening with a broad range of furanolide core structure analogs revealed a remarkable substrate promiscuity of these enzymes, making them valuable tools for biocatalytic late-stage diversification. In addition, an in-depth understanding of the biosynthetic sequence of the tailoring enzymes was obtained using early biosynthetic precursors: CybK, CybJ, and CybI sequentially orchestrate key cyanobacterin maturation steps, namely C10-hydroxylation, C10-O-methylation, and C8-chlorination, respectively. Following these modifications and subsequent furanolide core-structure assembly catalyzed by CybE/F, CybD installs the C17-methoxy group. Additionally, we identified and functionally characterized the ene-reductase CybG, which catalyzes the reduction of the C4-C13 double bond in cyanobacterins, transforming them into non-toxic saturated congeners. These insights not only enhance our understanding of the complex enzymatic pathway involved in cyanobacterin biosynthesis, but also facilitate the development of new tools for the enzymatic total synthesis of cyanobacterins and unnatural analogs, paving the way for future biotechnological applications.
- Open Access
- 14 October 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Chemo-enzymatic Total Synthesis and Combinatorial Biosynthesis of Maculalactones
Maculalactones are bioactive γ-butyrolactone natural products with promising antifouling properties, yet their limited availability constrains further development. Here, we report the identification and characterization of the key biosynthetic enzymes MacE and MacF from the maculalactone (mac) biosynthetic gene cluster in Nodularia sp. NIES-3585. In vitro reconstitution confirmed that MacE catalyzes acyloin condensation between phenylpyruvic acids, while MacF mediates subsequent fusion of the MacE product with cinnamoyl-CoA derivatives. Structure-guided engineering improved enzyme solubility, enabling systematic substrate scope expansion. Through a one-pot enzymatic synthesis, we synthesized 13 maculalactone derivatives with yields reaching more than 96%, while a complementary combinatorial biosynthesis approach enabled the incorporation of sterically demanding indole moieties, thereby significantly expanding the maculalactone structural space. Bioactivity screening against A549 lung adenocarcinoma cells revealed moderate cytotoxicity (IC₅₀ = 20.82–56.64 μM), with methylation of phenol groups significantly enhancing activity. Several analogs exhibited notable antibacterial activity against clinically relevant Gram-positive pathogens, including Streptococcus pneumoniae. Our work provides a sustainable platform for producing structurally diverse maculalactones, laying the foundation for future biomedical applications.
- 14 October 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessChemo-enzymatic Total Synthesis and Combinatorial Biosynthesis of Maculalactones
Maculalactones are bioactive γ-butyrolactone natural products with promising antifouling properties, yet their limited availability constrains further development. Here, we report the identification and characterization of the key biosynthetic enzymes MacE and MacF from the maculalactone (mac) biosynthetic gene cluster in Nodularia sp. NIES-3585. In vitro reconstitution confirmed that MacE catalyzes acyloin condensation between phenylpyruvic acids, while MacF mediates subsequent fusion of the MacE product with cinnamoyl-CoA derivatives. Structure-guided engineering improved enzyme solubility, enabling systematic substrate scope expansion. Through a one-pot enzymatic synthesis, we synthesized 13 maculalactone derivatives with yields reaching more than 96%, while a complementary combinatorial biosynthesis approach enabled the incorporation of sterically demanding indole moieties, thereby significantly expanding the maculalactone structural space. Bioactivity screening against A549 lung adenocarcinoma cells revealed moderate cytotoxicity (IC₅₀ = 20.82–56.64 μM), with methylation of phenol groups significantly enhancing activity. Several analogs exhibited notable antibacterial activity against clinically relevant Gram-positive pathogens, including Streptococcus pneumoniae. Our work provides a sustainable platform for producing structurally diverse maculalactones, laying the foundation for future biomedical applications.
- Open Access
- 21 May 2025
- Published by American Chemical Society (ACS) in ChemRxiv
A Chemo-Enzymatic Platform for Furanolide Synthesis and Functional Exploration
Furanolides represent an emerging class of natural products known for their structural diversity and potent bioactivities, including antibiotic, cytotoxic, or algicidal effects. The systematic exploration of their biological activity profiles for the discovery of new hits for drug development thus constitutes a promising endeavor. However, their low natural abundance and the resulting difficul-ty in obtaining sufficient quantities have limited further in-depth investigations into their biological activity and structure-activity relationships (SAR). Building on our recent discovery of biosynthetic enzymes catalyzing furanolide core-structure assembly, we herein developed a cost-effective, one-pot enzymatic toolbox that enables the fast generation of hundreds of furanolide structural analogs. We systematically evaluated antimicrobial activities and cytotoxicity against the A549 lung cancer cell line for a repre-sentative selection of library congeners and explored their SAR. Several derivatives demonstrated significant cytotoxicity, particu-larly against lung cancer stem cells, offering promising insights into the development of furanolides as potential anticancer agents. Additionally, some analogs displayed promising antibacterial activity against important Gram-positive pathogens such as Staphylo-coccus aureus.
- 21 May 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessA Chemo-Enzymatic Platform for Furanolide Synthesis and Functional Exploration
Furanolides represent an emerging class of natural products known for their structural diversity and potent bioactivities, including antibiotic, cytotoxic, or algicidal effects. The systematic exploration of their biological activity profiles for the discovery of new hits for drug development thus constitutes a promising endeavor. However, their low natural abundance and the resulting difficul-ty in obtaining sufficient quantities have limited further in-depth investigations into their biological activity and structure-activity relationships (SAR). Building on our recent discovery of biosynthetic enzymes catalyzing furanolide core-structure assembly, we herein developed a cost-effective, one-pot enzymatic toolbox that enables the fast generation of hundreds of furanolide structural analogs. We systematically evaluated antimicrobial activities and cytotoxicity against the A549 lung cancer cell line for a repre-sentative selection of library congeners and explored their SAR. Several derivatives demonstrated significant cytotoxicity, particu-larly against lung cancer stem cells, offering promising insights into the development of furanolides as potential anticancer agents. Additionally, some analogs displayed promising antibacterial activity against important Gram-positive pathogens such as Staphylo-coccus aureus.